VALN - Hot Stocks: DIS UPST downgrades; OXY gets higher price target; AVDL regulatory review; VALN clinical data

Analysts' notes and drug development headlines inspired significant stock movement in Monday's midday trading. This included one of the world's biggest entertainment conglomerates, with Disney (NYSE:DIS) losing ground in the wake of a downgrade from Barclays. Upstart (NASDAQ:UPST) also dipped following an analyst's downgrade. Meanwhile, Occidental Petroleum (NYSE:OXY) rallied following an increased price target. On the drug development side, Avadel (NASDAQ:AVDL) posted a double-digit percentage decline on news of a delayed regulatory review. Elsewhere, Valneva (NASDAQ:VALN) expanded its value by more than a third following strong clinical results for its COVID vaccine candidate. Decliners Disney (DIS) fell nearly 3% in midday action following a downgrade from Barclays. The firm cut DIS from Overweight to Equal Weight on worries about the entertainment giant's streaming forecast. Another downgrade put pressure on Upstart (UPST). Bank of America reduced its rating on the stock to Underperform from Buy. BofA cited UPST's recent run-up for

For further details see:

Hot Stocks: DIS, UPST downgrades; OXY gets higher price target; AVDL regulatory review; VALN clinical data